MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611059965 A) filed by Noida Institute Of Engineering And Technology Pharmacy Institute on May 12, 2026, for A High Stability Vaccine Formulation Platform.
Inventors include Anmol Dogra; and Dr. Rajnish Kumar.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: The present invention relates to a high stability vaccine formulation platform comprising an antigen phase, stabilization matrix, buffer and tonicity module, optional adjuvant interface control module, oxygen and moisture control module, carrier system, and container closure unit. The platform preserves antigen integrity, controls adjuvant behavior, reduces degradation pathways, and supports liquid or reconstitutable vaccine presentation. The formulation is compatible with conventional sterile manufacturing and quality evaluation, thereby improving storage resilience, dose uniformity, and administration reliability under practical vaccine distribution conditions.
Disclaimer: Curated by HT Syndication.
